Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab

Summary

Primary: to compare the overall survival defined as the time elapsed between the randomization date and death due to any cause, in both treatment groups. Secondary: to compare the progression-free survival, incidence of locoregional failure, site of the first recurrence/progression, objective response rate assessment, quality of life assessment and incidence of adverse events.

Timeline

Start

2013-11

Primary completion

2013-11

Completion

2017-11

Drugs

Indications